Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 112 results:
Συντάκτης Τίτλος [ Τύπος(Asc)] Έτος
Φίλτρα: Συντάκτης is Anagnostis, Panagiotis  [Clear All Filters]
Journal Article
Anagnostis, P., Vaitsi K., Veneti S., Georgiou T., Paschou S. A., Lambrinoudaki I., et al. (2019).  Management of dyslipidaemias in the elderly population-A narrative review.. Maturitas. 124, 93-99.
Anagnostis, P., Paschou S. A., & Goulis D. G. (2018).  Management of Acute Hip Fracture.. N Engl J Med. 378(10), 971-2.
Anagnostis, P., Adamidou F., Polyzos S. A., Efstathiadou Z., Karathanassi E., & Kita M. (2012).  Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience.. Pituitary. 15(1), 25-9.
Anagnostis, P., Karras S., Lambrinoudaki I., Stevenson J. C., & Goulis D. G. (2016).  Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options.. Int J Clin Pract. 70(12), 967-977.
Anagnostis, P., Kenanidis E., Potoupnis M., Tsiridis E., & Goulis D. G. (2020).  Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: an Endocrine Society Clinical Practice Guideline".. J Clin Endocrinol Metab. 105(1), 
Anagnostis, P., & Goulis D. G. (2019).  Letter to the Editor: "Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease".. J Clin Endocrinol Metab. 104(8), 3124.
Paschou, S. A., Anagnostis P., Goulis D. G., Siasos G., & Vryonidou A. (2018).  Letter to the Editor: "Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program".. J Clin Endocrinol Metab. 103(5), 2066-2067.
Anagnostis, P., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2011).  Impact of statins on glucose metabolism--a matter of debate.. Am J Cardiol. 107(12), 1866.
Athyros, V. G., Tziomalos K., Katsiki N., Gossios T. D., Giouleme O., Anagnostis P., et al. (2013).  The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study.. Curr Vasc Pharmacol. 11(5), 779-84.
Anagnostis, P., Vakalopoulou S., Slavakis A., Simoulidou E., Rakitzi P., Garipidou V., et al. (2009).  Hypoglycemia in a patient with advanced Sezary syndrome.. Leuk Lymphoma. 50(2), 284-6.
Anagnostis, P., Paschou S. A., Kenanidis E., Lambrinoudaki I., Potoupnis M., Tsiridis E., et al. (2019).  "Holidays" for osteoporosis drugs: A case-based approach.. Case Rep Womens Health. 23, e00127.
Gotsis, E., Anagnostis P., Mariolis A., Vlachou A., Katsiki N., & Karagiannis A. (2015).  Health benefits of the Mediterranean Diet: an update of research over the last 5 years.. Angiology. 66(4), 304-18.
Anagnostis, P., Karras S., Paschou S. A., & Goulis D. G. (2015).  Haemophilia A and B as a cause for secondary osteoporosis and increased fracture risk.. Blood Coagul Fibrinolysis. 26(6), 599-603.
Pontikides, N., Karras S., Kaprara A., Anagnostis P., Mintziori G., Goulis D. G., et al. (2014).  Genetic basis of familial isolated hyperparathyroidism: a case series and a narrative review of the literature.. J Bone Miner Metab. 32(4), 351-66.
Bosdou, J. K., Anagnostis P., Lainas G. T., & Kolibianakis E. M. (2020).  Female infertility and cardiovascular risk - a hype or an underestimated reality?. Curr Pharm Des.
Panoulis, K., Christantoni E., Pliatsika P., Anagnostis P., Goulis D. G., Kondi-Pafiti A., et al. (2015).  Expression of gonadal steroid receptors in the ovaries of post-menopausal women with malignant or benign endometrial pathology: a pilot study.. Gynecol Endocrinol. 31(8), 613-7.
Anagnostis, P., Bosdou J. K., Vaitsi K., Goulis D. G., & Lambrinoudaki I. (2020).  Estrogen and bones after menopause: a reappraisal of data and future perspectives.. Hormones (Athens).
Anagnostis, P., Karagiannis A., Tziomalos K., Athyros V. G., Kita M., & Mikhailidis D. P. (2010).  Endocrine hypertension: diagnosis and management of a complex clinical entity.. Curr Vasc Pharmacol. 8(5), 646-60.
Anagnostis, P., Goulis D. G., & Mikhailidis D. P. (2020).  Endocrine Disease as a Cause of Cardiovascular Disease: Current Perspectives.. Curr Pharm Des. 26(43), 5547-5550.
Kosmopoulos, M., Paschou S. A., Grapsa J., Anagnostis P., Vryonidou A., Goulis D. G., et al. (2019).  The Emerging Role of Bone Markers in Diagnosis and Risk Stratification of Patients With Coronary Artery Disease.. Angiology. 70(8), 690-700.
Anagnostis, P., Paschou S. A., Gkekas N. N., Artzouchaltzi A-M., Christou K., Stogiannou D., et al. (2018).  Efficacy of anti-osteoporotic medications in patients with type 1 and 2 diabetes mellitus: a systematic review.. Endocrine. 60(3), 373-383.
Anagnostis, P., Vaitsi K., Kleitsioti P., Mantsiou C., Pavlogiannis K., Athyros V. G., et al. (2020).  Efficacy and safety of statin use in children and adolescents with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized-controlled trials.. Endocrine.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Paraskevas K. I., Tziomalos K., Anagnostis P., et al. (2008).  Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study.. Curr Med Res Opin. 24(6), 1593-9.
Anagnostis, P., Karras S. N., Athyros V. G., Annweiler C., & Karagiannis A. (2014).  The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes.. Lancet Diabetes Endocrinol. 2(5), 362-3.
Gkekas, N. K., Anagnostis P., Paraschou V., Stamiris D., Dellis S., Kenanidis E., et al. (2021).  The effect of vitamin D plus protein supplementation on sarcopenia: A systematic review and meta-analysis of randomized controlled trials.. Maturitas. 145, 56-63.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.